作者
Barbara H Braffett, Gayle M Lorenzi, Catherine C Cowie, Xiaoyu Gao, Kathleen E Bainbridge, Karen J Cruickshanks, John R Kramer, Rose A Gubitosi-Klug, Mary E Larkin, Annette Barnie, John M Lachin, David S Schade, DCCT/EDIC Research Group
发表日期
2019/12
期刊
Endocrine Practice
卷号
25
期号
12
页码范围
1243-1254
出版商
American Association of Clinical Endocrinologists Corporation, INC.
简介
Objective: Studies have demonstrated that glycated hemoglobin (HbA1c) is a significant predictor of hearing impairment in type 1 diabetes. We identified additional factors associated with hearing impairment in participants with type 1 diabetes from the Diabetes Control and Complications Trial and its observational follow-up, the Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study.
Methods: A total of 1,150 DCCT/EDIC participants were recruited for the Hearing Study. A medical history, physical measurements, and a self-administered hearing questionnaire were obtained. Audiometry was performed by study-certified personnel and assessed centrally. Logistic regression models assessed the association of risk factors and comorbidities with speech- and high-frequency hearing impairment.
Results: Mean age was 55 ± 7 years, duration of diabetes 34 ± 5 years, and DCCT/EDIC HbA1c 7.9 ± …
学术搜索中的文章
BH Braffett, GM Lorenzi, CC Cowie, X Gao… - Endocrine Practice, 2019